Contineum Therapeutics (CTNM) Non-cash Items (2023 - 2025)

Contineum Therapeutics' Non-cash Items history runs 3 years deep, the most recent figure standing at $19.9 million for Q3 2025.

• In Q3 2025, Non-cash Items fell 49.1% year-over-year to $19.9 million; the TTM figure through Sep 2025 stood at $19.9 million (down 49.1% YoY), while the FY2024 annual figure was $21.5 million, up 44.21% from the prior year.
• Non-cash Items was $19.9 million for Q3 2025 at Contineum Therapeutics, up from $2.6 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $39.0 million in Q3 2024 to a low of $2.6 million in Q2 2025.
• Historically, Non-cash Items has averaged $20.5 million across 3 years, with a median of $20.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Non-cash Items surged 44.21% in 2024, then slumped 92.06% in 2025.
• A 3-year view of Non-cash Items shows it stood at $14.9 million in 2023, then jumped by 44.21% to $21.5 million in 2024, then fell by 7.51% to $19.9 million in 2025.
• The last three Non-cash Items figures came in at $19.9 million (Q3 2025), $2.6 million (Q2 2025), and $5.9 million (Q1 2025), per Business Quant data.